四川成渝高速公路(00107.HK):控股股東擬增持不超公司2%股份 當日已增持441.2萬股H股
格隆匯4月21日丨四川成渝高速公路(00107.HK)公佈,於2022年4月21日,控股股東蜀道投資通過聯交所交易系統購入441.2萬股H股股份,約佔公司已發行總股本的0.14%。
股份增持後,蜀道投資持有10.36億股A股股份及6526.62萬股H股股份,合計持有11.01億股股份,約佔公司已發行總股本的36.01%。
基於對目前資本市場形勢的認識及對公司未來持續穩定發展的信心,蜀道投資計劃在未來12個月內(自公吿日起計)擇機對公司股份進行增持,而累計增持量不超過公司現有總股份的2%(含股份增持項下的441.2萬股H股)。蜀道投資承諾,從是次股份增持之日起至增持計劃實施完畢之日止及法定期限內,不減持其持有的股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.